NASVAC to hit in Bangaldesh, plz have ur insite in to this

[kbl678]

http://www.bssnews.net/newsDetails.php?cat=0&id=697959&date=2017-10-24

[StephenCastlecrag]

The international clinical phase 2b  trials for ABX203, also known as NasVac, HeberNasVac, were abondoned because ABX203 was unlikely to achieve the trials' endpoints. This was in sharp contrast to the results obtained in a clinical trial conducted in Bangladesh. So far HeberNasVac is approved in Cuba(its original place of invention of this therapeutic vaccine), and we have heard very little about its effectiveness out of Cuba. So be careful and don't believe the hype from the local press.

[Jatashankar]

Yes correct.. the results of the trials are not very clearly published. Some links show results awaiting or trials ongoing. No definite result announced yet

[landloper]

The clinical trials that they were running, and were prematurely stopped because they were very unlikely to reach their endpoints, sound strangely designed from the start.

From memory they specifically selected people who had previously taken antivirals previously, and whose antivirals had failed them.

They never tested them on regular HBV patients.

Seeing the results of this now that it's on the market will be very interesting. I hope that there is some information posted in this forum.

[landloper]

I've been interested in NASVAC for years. It does not seem to be available anywhere (eg in Ecuador) even though that article says that it's approved. I don't know what's going on with it.

[ggtm]

This looks very promising indeed. I wonder why it is not mentioned in other countries. Im just afraid it may not pull through in the end due to some reasons. Maybe some of our more knowledgeable members can share their views?